Public Health

with 

KHN’s ‘What the Health?’: Much Ado About Drug Prices

Democrats have hit a snag in their effort to compile a $3.5 trillion social-spending bill this fall — moderates are resisting support for Medicare drug price negotiation provisions that would pay for many of the measure’s health benefit improvements. Meanwhile, the new abortion restrictions in Texas have moved the divisive issue back to the political front burner. Alice Miranda Ollstein of Politico, Rachel Cohrs of Stat and Shefali Luthra of The 19th join KHN’s Julie Rovner to discuss these issues and more. Also this week, Rovner interview’s KHN’s Phil Galewitz about the latest KHN-NPR “Bill of the Month” installment, about two similar jaw surgeries with very different price tags.

How Fauci and the NIH Got Ahead of the FDA and CDC in Backing Boosters

With real-time data streaming in from highly specialized researchers in the U.S. and abroad, NIH scientists became convinced that boosting the covid-19 vaccine was needed to save lives, prompting the president to announce a plan with a Sept. 20 start date. Scientists at the regulatory agencies weren’t yet convinced. A meeting Friday will determine what happens next. Here’s the story from behind the scenes.

Más de la mitad de los estados han revertido poderes de salud pública durante la pandemia

Motivados por votantes enojados por los cierres y los mandatos sobre el uso de máscaras durante la pandemia, legisladores republicanos en más de la mitad de los estados de EE.UU. están quitando los poderes que los funcionarios estatales y locales usan para proteger al público contra las enfermedades infecciosas

KHN’s ‘What the Health?’: The Future of Public Health

The covid pandemic has spotlighted the often-unseen role of public health in Americans’ daily lives. And the picture has not all been pretty. What is public health and why is it so important — and controversial? Dr. Ashish Jha, dean of the Brown University School of Public Health, explains the basics. Then, Joanne Kenen of Politico and Lauren Weber of KHN join KHN’s Julie Rovner to discuss what could happen next.